Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone in Adults With ADHD
NCT01873729Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Nov 2013; status: completed.
02
Drugs
naltrexone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01873729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01873729.